US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

33.73

-0.8400-2.43%

Post-market: 33.730.00000.00%17:06 EDT

Volume:288.05K

Turnover:9.93M

Market Cap:949.37M

PE:-19.06

High:35.49

Open:35.35

Low:33.65

Close:34.57

Loading ...

Overview Company News Filings

Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference

Ocumension Therapeutics (1477) was downgraded to a Hold Rating at Goldman Sachs

Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Development with Expert Advisory Board

Top Executive Sells Thousands of Shares in Serina Therapeutics!

Neurizon Therapeutics Advances Towards Lifting FDA Hold on ALS Treatment

Ocumension Therapeutics (HKG:1477 shareholders incur further losses as stock declines 6.0% this week, taking five-year losses to 74%

Simply Wall St.

Stoke Therapeutics Files $400 Million Mixed Shelf

MT Newswires Live

Candel Therapeutics initiated with a Buy at Brookline

ZyVersa Therapeutics Enters Warrant Exercise Agreement

Kazia Therapeutics Announces Promising Early Results in Breast Cancer Trial

Stoke Therapeutics files $400M mixed securities shelf

CARsgen Therapeutics Holdings Ltd. (2171) Receives a Sell from Goldman Sachs

Ernexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule

MT Newswires Live

Coya Therapeutics Initiated at Buy by Lake Street

Ernexa Therapeutics regains compliance with Nasdaq listing rules

Coya Therapeutics initiated with a Buy at Lake Street

Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines

Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit

Argenica Therapeutics Issues New Shares Following Option Exercise

Argenica Therapeutics Announces Cessation of Securities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LENZ/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":33.73,"timestamp":1752868800000,"preClose":34.57,"halted":0,"volume":288046,"hourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"delay":0,"floatShares":12538526,"shares":28146154,"eps":-1.769251,"marketStatus":"Market Closed","change":-0.84,"latestTime":"07-18 16:00:00 EDT","open":35.35,"high":35.485,"low":33.645,"amount":9926090.220002001,"amplitude":0.053225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":34.57,"preHourTrading":{"tag":"盘前","latestPrice":35.3,"preClose":34.57,"latestTime":"09:29 EDT","volume":499,"amount":17604.058825,"timestamp":1752845399999},"postHourTrading":{"tag":"盘后","latestPrice":33.73,"preClose":33.73,"latestTime":"17:06 EDT","volume":775,"amount":26162.6,"timestamp":1752872785598},"volumeRatio":0.8035328724389679,"impliedVol":1.0249,"impliedVolPercentile":0.8986},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12538526,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.8035328724389679,"shares":28146154,"dividePrice":0,"high":35.485,"amplitude":0.053225,"preClose":34.57,"low":33.645,"week52Low":16.535,"pbRate":"4.94","week52High":38.93,"institutionHeld":0,"latestPrice":33.73,"eps":-1.769251,"divideRate":0,"volume":288046,"delay":0,"ttmEps":-1.769251,"open":35.35,"prevYearClose":28.87,"prevWeekClose":34.69,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":34.69,"twentyDayClose":30.03,"sixtyDayClose":25.79},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550264240","title":"Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2550264240","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550264240?lang=en_us&edition=fundamental","pubTime":"2025-07-10 19:30","pubTimestamp":1752147000,"startTime":"0","endTime":"0","summary":"The Joint Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO) focus on the rapidly evolving area of central nervous system metastases Presentations will highlight the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/10/3113140/0/en/Plus-Therapeutics-Announces-Two-CNSide-Presentations-at-the-Upcoming-SNO-ASCO-CNS-Metastases-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSF","BK4539","BK4135","LENZ","CNS","BK4139","BK4007"],"gpt_icon":0},{"id":"2550863612","title":"Ocumension Therapeutics (1477) was downgraded to a Hold Rating at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550863612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550863612?lang=en_us&edition=fundamental","pubTime":"2025-07-10 16:35","pubTimestamp":1752136518,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Ziyi Chen downgraded Ocumension Therapeutics to a Hold on July 8 and set a price target of HK$9.78. The company’s shares clos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ocumension-therapeutics-1477-was-downgraded-to-a-hold-rating-at-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ocumension-therapeutics-1477-was-downgraded-to-a-hold-rating-at-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2550612897","title":"Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Development with Expert Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2550612897","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550612897?lang=en_us&edition=fundamental","pubTime":"2025-07-10 16:33","pubTimestamp":1752136429,"startTime":"0","endTime":"0","summary":"Rakovina Therapeutics Inc ( ($TSE:RKV) ) has provided an announcement. Rakovina Therapeutics has highlighted the strength of its Scientific Advisor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-strengthens-ai-driven-cancer-drug-development-with-expert-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-strengthens-ai-driven-cancer-drug-development-with-expert-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2550069327","title":"Top Executive Sells Thousands of Shares in Serina Therapeutics!","url":"https://stock-news.laohu8.com/highlight/detail?id=2550069327","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550069327?lang=en_us&edition=fundamental","pubTime":"2025-07-10 10:02","pubTimestamp":1752112930,"startTime":"0","endTime":"0","summary":"New insider activity at Serina Therapeutics ( ($SER) ) has taken place on July 9, 2025. CSO Moreadith Randall recently sold 6,500 shares of Serina ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-sells-thousands-of-shares-in-serina-therapeutics-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-sells-thousands-of-shares-in-serina-therapeutics-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2550644566","title":"Neurizon Therapeutics Advances Towards Lifting FDA Hold on ALS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2550644566","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550644566?lang=en_us&edition=fundamental","pubTime":"2025-07-10 08:08","pubTimestamp":1752106110,"startTime":"0","endTime":"0","summary":"Pharmaust Limited ( ($AU:NUZ) ) just unveiled an update. Neurizon Therapeutics Limited has received positive feedback from the FDA regarding its st...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurizon-therapeutics-advances-towards-lifting-fda-hold-on-als-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurizon-therapeutics-advances-towards-lifting-fda-hold-on-als-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2550698338","title":"Ocumension Therapeutics (HKG:1477 shareholders incur further losses as stock declines 6.0% this week, taking five-year losses to 74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550698338","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550698338?lang=en_us&edition=fundamental","pubTime":"2025-07-10 07:53","pubTimestamp":1752105196,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics ( HKG:1477 ) shareholders will doubtless be very grateful to see the share price up 91% in the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1477/ocumension-therapeutics-shares/news/ocumension-therapeutics-hkg1477-shareholders-incur-further-l-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK4007","BK4539","01477","BK1574","BK1191","BK4139"],"gpt_icon":0},{"id":"2550266689","title":"Stoke Therapeutics Files $400 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2550266689","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550266689?lang=en_us&edition=fundamental","pubTime":"2025-07-10 05:33","pubTimestamp":1752096829,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics  late Wednesday filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $400 million of securities from time to time.The filing covers common and preferred shares, debt securities, warrants, subscription rights, and units.Net proceeds are intended for general corporate purposes, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","BK4007","STOK","LENZ"],"gpt_icon":0},{"id":"2550665677","title":"Candel Therapeutics initiated with a Buy at Brookline","url":"https://stock-news.laohu8.com/highlight/detail?id=2550665677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550665677?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:55","pubTimestamp":1752094518,"startTime":"0","endTime":"0","summary":"Brookline analyst Kemp Dolliver initiated coverage of Candel Therapeutics (CADL) with a Buy rating and $25 price target Candel is a clinical stage ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-initiated-with-a-buy-at-brookline-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-initiated-with-a-buy-at-brookline-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","BRKL","CADL","BK4211","BK4539"],"gpt_icon":0},{"id":"2550665984","title":"ZyVersa Therapeutics Enters Warrant Exercise Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2550665984","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550665984?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:53","pubTimestamp":1752094439,"startTime":"0","endTime":"0","summary":"The latest announcement is out from ZyVersa Therapeutics ( ($ZVSA) ). On July 8, 2025, ZyVersa Therapeutics entered into a warrant exercise inducem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zyversa-therapeutics-enters-warrant-exercise-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zyversa-therapeutics-enters-warrant-exercise-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2550663033","title":"Kazia Therapeutics Announces Promising Early Results in Breast Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663033?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:27","pubTimestamp":1752092849,"startTime":"0","endTime":"0","summary":"An announcement from Kazia Therapeutics ( ($KZIA) ) is now available. On July 9, 2025, Kazia Therapeutics announced promising early results from a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kazia-therapeutics-announces-promising-early-results-in-breast-cancer-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kazia-therapeutics-announces-promising-early-results-in-breast-cancer-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2550635016","title":"Stoke Therapeutics files $400M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2550635016","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550635016?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:05","pubTimestamp":1752091518,"startTime":"0","endTime":"0","summary":"16:04 EDT Stoke Therapeutics (STOK) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/stoke-therapeutics-files-400m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/stoke-therapeutics-files-400m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","STOK","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2550668214","title":"CARsgen Therapeutics Holdings Ltd. (2171) Receives a Sell from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550668214","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550668214?lang=en_us&edition=fundamental","pubTime":"2025-07-10 03:55","pubTimestamp":1752090940,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Ziyi Chen maintained a Sell rating on CARsgen Therapeutics Holdings Ltd. today and set a price target of HK$14.92. The compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/carsgen-therapeutics-holdings-ltd-2171-receives-a-sell-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/carsgen-therapeutics-holdings-ltd-2171-receives-a-sell-from-goldman-sachs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0004091025.USD","LU2750360997.AUD","BK4550","BK4533","LU1668664300.SGD","BK4007","LU2750360641.GBP","LU1791807156.HKD","LU1868836591.USD","BK4139","LU2237443465.HKD","LU2237443622.USD","LU2471134523.USD","BK4539","LU1894683264.USD","BK4588","LU0061475181.USD","LU2471134952.CNY","LU0106831901.USD","BK4585","BK4504","LU0742534661.SGD","LU1868836757.USD","LENZ","BK4127","LU0048573561.USD","LU2237443978.SGD","IE0004086264.USD","LU2237443382.USD","IE0034235188.USD","LU1894683348.USD","LU0251142724.SGD","IE00B19Z3B42.SGD","BK4552","IE0002270589.USD","IE00BFXG1179.USD","LU2237438978.USD","LU0251131958.USD","BK4516","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1868837300.USD","LU2471134796.USD","LU2237443895.HKD","LU2471134879.HKD","LU0096364046.USD","LU2237443549.SGD","LU1868836914.USD","LU1868837136.USD"],"gpt_icon":0},{"id":"2550265618","title":"Ernexa Therapeutics Regains Nasdaq Compliance Over Minimum Bid Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2550265618","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550265618?lang=en_us&edition=fundamental","pubTime":"2025-07-09 22:42","pubTimestamp":1752072152,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics  on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Stock Market.The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.Shares of Ernexa Therapeutics were up 1.6% in recent trading.Price: 1.95, Change: +0.03, Percent Change: +1.56","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","ERNA","IE00BGHQF748.EUR","BK4007","TQQQ","USAW.SI","QLD","NVIW.SI","IE00BKPKM429.USD","NDAQ","TSYW.SI","LU2095319765.USD","USJW.SI",".IXIC","NQmain","LU2210149790.SGD","QID","IE00B64PRP62.GBP","MNQmain","SQQQ","LU2210150020.SGD","IE00B3QW5Z07.USD","LENZ","BK4585","BK4588","BK4112","BK4139","PSQ"],"gpt_icon":0},{"id":"2550655868","title":"Coya Therapeutics Initiated at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2550655868","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550655868?lang=en_us&edition=fundamental","pubTime":"2025-07-09 22:01","pubTimestamp":1752069660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/COYA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 09, 2025 10:01 ET (14:01 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LENZ","BK4539","COYA"],"gpt_icon":0},{"id":"2550637742","title":"Ernexa Therapeutics regains compliance with Nasdaq listing rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2550637742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550637742?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:40","pubTimestamp":1752064848,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics (ERNA) regained compliance with Nasdaq for continued listing and that its stock will continue to trade on The Nasdaq Stock Mark...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-regains-compliance-with-nasdaq-listing-rules-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ernexa-therapeutics-regains-compliance-with-nasdaq-listing-rules-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNQmain","BK4539","BK4139",".IXIC","IE00B64PRP62.GBP","SQQQ","USAW.SI","TQQQ","PSQ","LU2210149790.SGD","IE00BGHQF748.EUR","LU2095319765.USD","BK4585","QID","BK4588","NQmain","LU2210150020.SGD","QLD","BK4007","IE00B3QW5Z07.USD","LENZ","USJW.SI","NVIW.SI","NDAQ","IE00BKPKM429.USD","TSYW.SI","BK4112","ERNA"],"gpt_icon":0},{"id":"2550370856","title":"Coya Therapeutics initiated with a Buy at Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2550370856","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550370856?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:40","pubTimestamp":1752064837,"startTime":"0","endTime":"0","summary":"Lake Street initiated coverage of Coya Therapeutics (COYA) with a Buy rating and $16 price target The firm says the company’s anti-inflammation pla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-initiated-with-a-buy-at-lake-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coya-therapeutics-initiated-with-a-buy-at-lake-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COYA","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2550199637","title":"Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines","url":"https://stock-news.laohu8.com/highlight/detail?id=2550199637","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550199637?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:30","pubTimestamp":1752064200,"startTime":"0","endTime":"0","summary":"Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery System; Company is Currently Conducting Additional Studies into New and Previ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/09/3112544/0/en/Silexion-Therapeutics-Announces-Positive-Results-in-Preclinical-Study-Demonstrating-Significant-SIL204-Efficacy-in-Human-Lung-Cancer-Cell-Lines.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ"],"gpt_icon":0},{"id":"2550063297","title":"Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2550063297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550063297?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:00","pubTimestamp":1752062400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., July  09, 2025  (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/09/3112488/0/en/Werewolf-Therapeutics-to-Participate-in-the-KidneyCAN-7th-Annual-Kidney-Cancer-Research-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","BK4139","HOWL","RCC","LENZ","SMMF","BK4211"],"gpt_icon":0},{"id":"2550861216","title":"Argenica Therapeutics Issues New Shares Following Option Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2550861216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550861216?lang=en_us&edition=fundamental","pubTime":"2025-07-09 15:18","pubTimestamp":1752045499,"startTime":"0","endTime":"0","summary":"The latest update is out from Argenica Therapeutics Ltd ( ($AU:AGN) ). Argenica Therapeutics Limited has issued 10,522 fully paid ordinary shares f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-issues-new-shares-following-option-exercise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-issues-new-shares-following-option-exercise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2550686155","title":"Argenica Therapeutics Announces Cessation of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2550686155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550686155?lang=en_us&edition=fundamental","pubTime":"2025-07-09 15:17","pubTimestamp":1752045462,"startTime":"0","endTime":"0","summary":"Argenica Therapeutics Ltd ( ($AU:AGN) ) just unveiled an announcement. Argenica Therapeutics Ltd has announced the cessation of 113,478 securities,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-announces-cessation-of-securities-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/argenica-therapeutics-announces-cessation-of-securities-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-17","current":-20.747029,"percent":0,"low":-20.747029,"twenty":-15.811799,"median":-10.788339,"eighty":-7.479638,"high":-5.069183,"avg":-11.383781,"sd":4.077823,"marketCap":990463159},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-17","current":-20.747029,"twenty":-15.811799,"median":-10.788339,"eighty":-7.479638,"marketCap":990463159}],"updateTime":1752902791928}}}